Canine CA50 antibody and antigen (recombinant protein)
Diagnostic anti-Canine CA50 antibodies pairs and antigen for animal health (animal Dog/Canine pancreatic and colorectal cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-CA50-Ag01 | Recombinant Canine CA50 protein | 3090 |
GMP-CAN-CA50-Ab01 | Anti-Canine CA50 mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-CA50-Ab02 | Anti-Canine CA50 mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-CA50-Ab03 | Anti-Canine CA50 human monoclonal antibody (mAb) | 1953 |
GMP-CAN-CA50-Ab04 | Anti-Canine CA50 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-CA50-Ag01 |
Product Name | Recombinant Canine CA50 protein |
Target/Biomarker | Canine Carbohydrate Antigen 50 (AIV-A H9N2 subtype) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine Carbohydrate Antigen 50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AIV-A H9N2 subtype level test of animal Dog/Canine with pancreatic and colorectal cancer. |
Tag | His |
Products description | Recombinant Canine CA50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-CA50-Ab01, GMP-CAN-CA50-Ab02 |
Product Name | Anti-Canine CA50 mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine Carbohydrate Antigen 50 (AIV-A H9N2 subtype) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine Carbohydrate Antigen 50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies in AIV-A H9N2 subtype level test of animal Dog/Canine with pancreatic and colorectal cancer. |
Tag | mFc |
Products description | Anti-Canine CA50 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-CA50-Ab03, GMP-CAN-CA50-Ab04 |
Product Name | Anti-Canine CA50 human monoclonal antibody (mAb) |
Target/Biomarker | Canine Carbohydrate Antigen 50 (AIV-A H9N2 subtype) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine Carbohydrate Antigen 50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies in AIV-A H9N2 subtype level test of animal Dog/Canine with pancreatic and colorectal cancer. |
Tag | hFc |
Products description | Anti-Canine CA50 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Carbohydrate Antigen 50 (CA50) is a glycoprotein biomarker with vital implications in canine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in dogs, with a significant focus on those affecting the gastrointestinal and pancreatic regions. Structurally, CA50 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules. In the context of canine health, CA50 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal and pancreatic regions can be insidious, often presenting with subtle or nonspecific clinical signs. CA50 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes. CA50 levels in a dog's bloodstream become elevated when cancer cells, particularly those found in gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA50 serves as a biomarker that can be readily detected and quantified through blood tests.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.